IO Biotech, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-23.5M | — |
| FY2020 | — | $-35.3M | $3.4M |
| FY2021 | — | $211.9M | $211.5M |
| FY2022 | — | $138.9M | $142.6M |
| FY2023 | — | $133.2M | $143.2M |
| FY2024 | $0 | $47.0M | $60.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-23.5M | — |
| FY2020 | — | $-35.3M | $3.4M |
| FY2021 | — | $211.9M | $211.5M |
| FY2022 | — | $138.9M | $142.6M |
| FY2023 | — | $133.2M | $143.2M |
| FY2024 | $0 | $47.0M | $60.0M |